• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBC100502
Device Problem Insufficient Information (3190)
Patient Problems Occlusion (1984); Thrombosis (2100)
Event Date 04/11/2018
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records could not be performed as device item/lot numbers were not available.The images and device were no available , the imaging evaluation and engineering evaluation could not be performed.Two lot numbers were provided, only one device was involved in the reported issue.It was unknown which device was involved in the event.In this event, the second lot number was vbc100502/14197479.
 
Event Description
The following publication was reviewed: "combined surgical and endovascular treatment with arch preservation of acute debakey type i aortic dissection" received through "journal of chinese medical association.(2019) 82: 209-214".The author: chiao-po hsu, chun-yang huang, hsiang-ting chend.The hospital: surgery, department of surgery, taipei veterans general hospital, taipei, taiwan, roc; department of surgery, taoyuan general hospital, ministry of health and welfare, taoyuan, taiwan, roc; department of nursing, taipei veterans general hospital, taipei, taiwan, roc.The article includes the following case: between december 2011 and december 2015, 12 patients with type i aortic dissection concomitant involving supraaortic vessels underwent ascending aortic replacement and simultaneous stent grafts inserted into the descending aorta, left subclavian, and left carotid arteries, and into the innominate artery when possible, without arch replacement.The stent grafts, gore tag thoracic endoprosthesis and viabahn, were deployed under visual guidance through opened aortic arch into the true lumen, with the techniques of circulatory arrest, moderate hypothermia, and bilateral antegrade cerebral perfusion.Reported results stated the j-curved guide wire with 5 cm viabahn was cannulated into the left subclavian artery (lsa) but kept in situ without deployment (usually 1.5 cm of covered stent was protruded into the arch lumen).Finally, remaining viabahn was deployed in the lsa.During 1-year postoperative follow-up, only one of 26 covered stents placed in supra-aortic branches showed thrombosis and occlusion.This stent was in the lsa, which did not cause obvious symptoms.
 
Manufacturer Narrative
H6 - code 213: review of device manufacturing record history confirmed both devices met pre-release specifications.Two lot numbers were provided by user facility.Only one gore® viabahn® endoprosthesis was involved in the reported issue and it is unknown which device was involved in the reported occlusion event.The second device lot number that was provided is: lot number 14197479; item number vbc100502.
 
Manufacturer Narrative
A2.Age at time of event, a3.Sex and a4 (lot# and catalog#)were updated.The article stated 5cm gore® viabahn® endoprosthesis into the left subclavian artery (lsa), therefore the device lot number was 14197479, item number was vbc100502.According to table 1 in the article, this was patient 5( female; 71 year old with aberrant right subclavian artery).
 
Manufacturer Narrative
Section d and h4 were updated with suspect medical device product information.Two device lot numbers were provided by user facility.Only one gore® viabahn® endoprosthesis was involved in the reported issue and it is unknown which device was involved in the reported event.Further review of the article seem to confirm a 5cm gore® viabahn® endoprosthesis was implanted in the patient's left subclavian artery (lsa).Therefore, the device lot number is updated to 14197479, item number was vbc100502.Mfr report# 2017233-2019-00848 was also reported based on this article.The same device lot number is used because we were unable to confirm with user facility which device was involved in this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9068747
MDR Text Key161937765
Report Number2017233-2019-00860
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/06/2018
Device Catalogue NumberVBC100502
Device Lot Number14236013
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/16/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received09/20/2019
09/24/2019
10/08/2019
10/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
-
-